Default Category
-
B9 Beverages: From Start-Up to Scale-Up
Sandeep Puri; Shalki Goel; Sanchita Krishna; Babak Hayati; Rakesh SinghCase IVEY-9B19A008-EEntrepreneurship, Marketing, StrategyIn May 2018, B9 Beverages Private Limited (B9 Beverages), the owner of craft beer Bira 91, reached a total of over US$100 million in funding after receiving $50 million from Sofina SA, a Belgian investment firm. This third round of funding would allow the company to meet the various objectives that the founder and chief executive officer had planned for the company’s new Bira 91. He wanted his India business to break even by 2019 and expand fivef...Starting at €8.20
-
Brewing Peace Philippines: Customer Relationship Management
Jose Gerardo Santamaria; Sandeep Puri; Maria Luisa Chua Delayco; Rakesh SinghCase IVEY-9B20A056-EEntrepreneurship, Marketing, StrategyBrewing Peace was a company based in the Philippines that sold coffee beans. Despite having a base of 80 customers, 70 per cent of its business depended on 9 key accounts; this included its biggest buyer, Concepcion Coffee Enterprises Limited (CCEL), whicStarting at €8.20
-
Grupo de Empresas Fortuny (B)
Álvarez, E.; Tàpies, JosepCase F-603FinanceDilema de Borja Lladó sobre si liderar una operación de tema de control a través de una MBO o simplemente vender la compañía al grupo inversor IDI.Starting at €5.74
-
Grupo de Empresas Fortuny (D)
Álvarez, E.; Tàpies, JosepCase F-605FinanceProblemas que pueden aparecer entre los distintos grupos de poder accionarial cuando alguno trata de liderar una operación de MBO sin haberse asegurado un consenso previo.Starting at €5.74
-
Maha Research Labs: Sales Force Effectiveness
Sandeep Puri; Rakesh Singh; Bindu Gupta; Shraddha PuriCase IVEY-W27721-EKnowledge and Communication, MarketingIn January 2022, Maha Research Labs Private Limited (MRL) needed to boost its sales force effectiveness (SFE). Due to the COVID-19 pandemic, MRL experienced losses in sales revenue and saw dwindling profits through 2020 and 2021. The pandemic had changed the sales ecosystem of the pharmaceutical industry, with many physicians and retailers now preferring online sales presentations. MRL’s managing director was concerned about the increased marketi...Starting at €8.20
-
Unilever: Using Horlicks’s Brand Equity to Lead
Sanchita Krishna; Sandeep Puri; Rakesh SinghCase IVEY-9B20A021-EMarketing, StrategyIn December 2018, Hindustan Unilever Limited announced that it would buy out GlaxoSmithKline Plc’s Consumer Healthcare Ltd. India business, which included popular brands such as Horlicks, Boost, and Viva. With Horlicks in its portfolio, Hindustan Unilever Limited expected to gain market share, draw synergies from individual strengths, and gain access to a larger consumer base. However, India’s health food drink category had registered only single...Starting at €8.20
-
Grupo de Empresas Fortuny (A)
Álvarez, E.; Tàpies, JosepCase F-602FinanceSe plantea la adquisición de un grupo de empresas familiares por un grupo inversor internacional que está dispuesto a comprar el cien por cien. Los directivos son accionistas, pero también hay accionistas que no tienen intervención en la gestión. El caso es de datos para poder hacer una evaluación de la sociedad y abre horizontes a la posibilidad de hacer una operación de MBO.Starting at €8.20
-
Grupo de Empresas Fortuny (C)
Álvarez, E.; Tàpies, JosepCase F-604FinanceEl caso permite reflexionar acerca de los riesgos que entraña la negociación con inversores financieros profesionales a la hora de vender una empresa o de hacerse con la mayoría a través de una MBO.Starting at €5.74
-
Grupo de Empresas Fortuny (E)
Álvarez, E.; Tàpies, JosepCase F-606FinanceExplica cómo acabaron los acontecimientos que se describen en los casos (A), (B) y (C).Starting at €5.74
-
Sarva Pharmaceuticals in Cambodia: Fight or Fold
Sandeep Puri; Rakesh Singh; Raj Agnihotri; Bindu GuptaCase IVEY-9B20A060-EEntrepreneurship, Marketing, StrategyIn January 2020, Jai Prakash Chaubey, the managing director of Sarva Pharmaceuticals Private Limited (Sarva), needed to decide whether or not to accept a proposal from Gursim Pharmaceutical Limited (Gursim) to market some of Sarva’s products in Cambodia. Sarva had been performing well; however, the company’s profitability in Cambodia was minimal. Should Chaubey accept Gursim’s offer? Or should he hire a new country head who could drive the sales ...Starting at €8.20